Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
15/11/2013
18/10/2013
18/10/2013
16/09/2013
02/09/2013
02/08/2013
02/08/2013
16/07/2013
15/07/2013
18/06/2013
17/06/2013
03/05/2013
24/04/2013
17/04/2013
17/04/2013
15/04/2013
15/03/2013
01/03/2013
18/02/2013
15/02/2013
15/01/2013
28/12/2012
17/12/2012
15/11/2012
15/10/2012
09/10/2012
26/09/2012
17/09/2012
26/07/2012
16/07/2012